IMPURITIES AVAILABLE FOR 'Resiquimod'

Omsynth Lifesciences Pvt. Ltd. is one of the leading manufacturer and exporter of Resiquimod. Resiquimod is an investigational immune response modifier that acts as an agonist of Toll-like receptors 7 and 8 (TLR7/8), stimulating innate and adaptive immunity. It promotes the production of cytokines such as interferon-alpha and tumor necrosis factor-alpha, enhancing antiviral and antitumor immune responses. Resiquimod is being studied for the treatment of viral infections, skin cancers (like cutaneous T-cell lymphoma), and as a vaccine adjuvant. It is typically applied topically in gel or cream form during clinical trials. Common side effects include local skin irritation, redness, and inflammation. It is not yet approved for clinical use but shows promising immunotherapeutic potential. Buy high quality Resiquimod from Omsynth Lifesciences.